EVerZom Team

We are driven by our shared belief in the therapeutic potential of exosomes.

Our mission is to work towards the democratization of exosome-based therapies: to bring affordable and easily accessible therapeutics to patients with unmet medical needs. Founded in Paris in 2019, EVerZom has received several prestigious international awards and recognitions for our technology. At EVerZom, we have successfully overcome the challenge of high-yield, large-scale and cost-effective exosome production and developed a unique proprietary innovation platform.

This breakthrough has opened up many potential clinical applications for exosome-based therapies. Our first naive exosome-based candidates have generated promising preclinical data in digestive healing and organs regeneration and our first program is expected to enter the clinic by 2026.

Additional programs are in our pipeline and our platform offers co-development opportunities in regenerative medicine.